Bio Pharma Services and ADA Medical in Collaboration

News Feb 21, 2014

Biopharma Services Inc. has announced that in collaboration with its sister company, ADA Medical Ltd., it can now offer a complete range of contract research services, from early pre-clinical drug development through to Phase I - IV clinical trials.

“ADA Medical’s pre-clinical drug development research services and late stage Phases IIb - IV medical research are a natural fit with Biopharma Services Inc. early stage Phases I - IIa” commented Renzo DiCarlo, CEO of Biopharma Services Inc. and ADA Medical Ltd.

ADA Medical’s existing project management skills coupled with Biopharma’s pharmacodynamics, pharmacokinetics, biostatistics, data management, regulatory and quality assurance capabilities bring the needed management and quality oversight to create the discipline needed for drug research and clinical trials.

PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

Anti-Malaria Drugs Delivered With Caffeine

News

Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas

News

First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.